These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2312178)

  • 41. Control of idiotope expression by monoclonal anti-idiotope and idiotope-bearing antibody.
    Kelsoe G; Reth M; Rajewsky K
    Eur J Immunol; 1981 May; 11(5):418-23. PubMed ID: 6790289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural difference in the complement activation site of human IgG1 and IgG3.
    Michaelsen TE; Sandlie I; Bratlie DB; Sandin RH; Ihle O
    Scand J Immunol; 2009 Dec; 70(6):553-64. PubMed ID: 19906198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular Basis of Assembly and Activation of Complement Component C1 in Complex with Immunoglobulin G1 and Antigen.
    Wang G; de Jong RN; van den Bremer ET; Beurskens FJ; Labrijn AF; Ugurlar D; Gros P; Schuurman J; Parren PW; Heck AJ
    Mol Cell; 2016 Jul; 63(1):135-45. PubMed ID: 27320199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Initial repertoire of anti-(4-hydroxy-3-nitrophenylacetyl) antibodies as potential donors for effective affinity maturation.
    Furukawa K; Manabe A; Furukawa A; Kuba H; Okajima T; Azuma T
    Mol Immunol; 2006 Apr; 43(11):1751-60. PubMed ID: 16406527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation.
    Russell MW; Reinholdt J; Kilian M
    Eur J Immunol; 1989 Dec; 19(12):2243-9. PubMed ID: 2606139
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.
    Brüggemann M; Williams GT; Bindon CI; Clark MR; Walker MR; Jefferis R; Waldmann H; Neuberger MS
    J Exp Med; 1987 Nov; 166(5):1351-61. PubMed ID: 3500259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. C1q augments platelet activation in response to aggregated Ig.
    Peerschke EI; Ghebrehiwet B
    J Immunol; 1997 Dec; 159(11):5594-8. PubMed ID: 9548501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional and molecular characterization of single, (4-hydroxy-3-nitrophenyl)acetyl (NP)-specific, IgG1+ B cells from antibody-secreting and memory B cell pathways in the C57BL/6 immune response to NP.
    Lalor PA; Nossal GJ; Sanderson RD; McHeyzer-Williams MG
    Eur J Immunol; 1992 Nov; 22(11):3001-11. PubMed ID: 1425924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delayed appearance of the catalytic activity by immunization of a rabbit compared with the hapten binding.
    Suzuki H; Sasaki K; Mukouyama EB; Kawamura-Konishi Y; Wada Y; Ono M
    Biochem Mol Biol Int; 1994 Aug; 34(1):27-35. PubMed ID: 7849622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative studies on biological activities of subcomponents C1q of the first component of human, bovine, mouse and guinea-pig complement.
    Sasaki T; Yonemasu K
    Biochim Biophys Acta; 1984 Mar; 785(3):118-22. PubMed ID: 6608375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clusterin binds by a multivalent mechanism to the Fc and Fab regions of IgG.
    Wilson MR; Easterbrook-Smith SB
    Biochim Biophys Acta; 1992 Oct; 1159(3):319-26. PubMed ID: 1390937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Strategy for affinity maturation of an antibody with high evolvability to (4-hydroxy-3-nitrophenyl) acetyl hapten.
    Furukawa K; Shimizu T; Murakami A; Kono R; Nakagawa M; Sagawa T; Yamato I; Azuma T
    Mol Immunol; 2007 Mar; 44(9):2436-45. PubMed ID: 17118452
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-IgM antibody decreases dissociability of cell bound IgM anti-hapten antibodies as measured with fluid phase hapten.
    Circolo A; Battista P; Borsos T
    Mol Immunol; 1987 Jul; 24(7):737-41. PubMed ID: 3498885
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of hemolytic complement by mouse monoclonal IgG1 antibody: comparison with rabbit IgG.
    Battista P; Circolo A; Borsos T
    Mol Immunol; 1985 Mar; 22(3):215-21. PubMed ID: 2582242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monoclonal Antibodies against Epidermal Growth Factor Receptor Acquire an Ability To Kill Tumor Cells through Complement Activation by Mutations That Selectively Facilitate the Hexamerization of IgG on Opsonized Cells.
    Tammen A; Derer S; Schwanbeck R; Rösner T; Kretschmer A; Beurskens FJ; Schuurman J; Parren PW; Valerius T
    J Immunol; 2017 Feb; 198(4):1585-1594. PubMed ID: 28062698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoantibodies against C1q in systemic lupus erythematosus are antigen-driven.
    Schaller M; Bigler C; Danner D; Ditzel HJ; Trendelenburg M
    J Immunol; 2009 Dec; 183(12):8225-31. PubMed ID: 20007586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation.
    Kovacs H; Campbell ID; Strong P; Johnson S; Ward FJ; Reid KB; Eggleton P
    Biochemistry; 1998 Dec; 37(51):17865-74. PubMed ID: 9922153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Binding of submaximal C1q promotes complement-dependent cytotoxicity (CDC) of B cells opsonized with anti-CD20 mAbs ofatumumab (OFA) or rituximab (RTX): considerably higher levels of CDC are induced by OFA than by RTX.
    Pawluczkowycz AW; Beurskens FJ; Beum PV; Lindorfer MA; van de Winkel JG; Parren PW; Taylor RP
    J Immunol; 2009 Jul; 183(1):749-58. PubMed ID: 19535640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pronounced effect of hapten binding on thermal stability of an anti-(4-hydroxy-3-nitrophenyl)acetyl antibody possessing a glycine residue at position 95 of the heavy chain.
    Sato Y; Inaba S; Fukada H; Azuma T; Oda M
    Mol Immunol; 2017 May; 85():130-136. PubMed ID: 28249223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.